Tolerance and Safety of a Duodenal Probe Monitoring the Microcirculation (MC Monitor)

Advanced Perfusion Diagnostics

Status: Completed

Conditions: Multiple Organ Dysfunction Syndrome

Treatments: Device: APD probe

Study type: Interventional

Funder types: Industry

Identifiers

NCT02246036

2014-A00989-38

Details and patient eligibility

About

For Intensive Care Units (ICU) patients, Multiple Organ Dysfunction Syndrome (MODS) is a very common complication yielding high morbidity and mortality. Inadequate regional perfusion of certain organs (gut, kidney, liver, etc) often caused by shock is the main cause of MODS. Current practice uses cardiac output data and blood pressure to manage shock but there are still lacks of information about the regional perfusion. This leads to late MODS diagnostics preventing the implementation of adequate treatment.

Gut perfusion monitoring seems to be a good target to assess the microcirculation but, nowadays, no practical methods or devices are available to measure the gut perfusion, and the current monitoring methods are not specific (CO, BP, OPS-SDF, PCO2, etc).

"MC Monitor" trial is a prospective, multi-center pilot study, enrolling 10 patients.

The probe will be used by intensivists on ICU patients with a risk of shock and requiring mechanical ventilation.

The probe will be placed in the patient with an endoscopic procedure by a gastroenterologist (standard procedure for post-pyloric tubes placement). This procedure will be used to assess the status of the gut mucosa prior to the placement of the APD probe.

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years of age or more,
• Male or female,
• ICU patient, on vasoactive amines, under mechanical ventilation,
• Stable hemodynamic status,
• Life expectancy expected to exceed 72 hours,
• Length of ICU stay greater than 5 days,
• Willing to participate and signed informed consent,
• Affiliation to the French social security system.

Exclusion criteria

• Pregnant or lactating woman,
• Ongoing enteral nutrition,
• Risk of gastrointestinal ischemia,
• History of pharyngeal surgery surgery, esophageal surgery, radiotherapy of mediastinal area,
• Known ear-nose-throat malignant disease,
• Unexplored dysphagia,
• Known recent gastrointestinal suture,
• Esophageal varices,
• Abdominal pain,
• Unstable cervical fracture,
• Moribund patient,
• Active participation in another investigational protocol within the past 30 days,
• Subject legally protected, under legal guardianship, deprived of his/her liberty by judicial or administrative decision.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

APD probe

Experimental group

Description:

Placement of a duodenal probe during 24 hours.

Treatment:

Device: APD probe